No Detail Found!

A Case of Euglycemic Diabetic Ketoacidosis due to Empagliflozin Use in a Patient with Type 1 Diabetes Mellitus

Author(s)
Satilmis Bilgin Department of Internal Medicine, Abant Izzet Baysal University Hospital,Bolu,Turkey
Tuba Taslamacioglu Duman Department of Internal Medicine, Abant Izzet Baysal University Hospital,Bolu,Turkey
Ozge Kurtkulagi Department of Internal Medicine, Abant Izzet Baysal University Hospital,Bolu,Turkey
Feyza Yilmaz Department of Internal Medicine, Abant Izzet Baysal University Hospital,Bolu,Turkey
Gulali Aktas Department of Internal Medicine, Abant Izzet Baysal University Hospital,Bolu,Turkey
Abstract
Euglycemic diabetic ketoacidosis is characterised by serum blood glucose <250 mg/dl, arterial blood pH <7.35, and the presence of ketones in urine or blood. Here, we present a 36-year female with type-1 diabetes mellitus, a case of euglycemic diabetic ketoacidosis, who was admitted to the emergency unit with nausea, vomiting, and confusion after using Empagliflozin, which was added to her treatment one month ago. She was followed up in the intensive care unit for four days. Empagliflozin was discontinued. Intravenous uids and insulin infusions were given. The patient, whose metabolic acidosis regressed, was discharged with the necessary recommendations and training. Euglycemic diabetic ketoacidosis should be kept in mind as a di erential diagnosis in patients with type-1 diabetes and type-2 diabetes presenting with acidosis. Attention should be paid to the patients medications and whether there are SGLT-2 inhibitors among these drugs.
Publication Details
Page(s) 928-930
DOI DOI not available
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 32, Issue: 7, Year: 2022

Request the full text from PASTIC

Keywords
Diabetes Mellitus, Euglycemic diabetic ketoacidosis, Sodium-glucose co-transporter-2 inhibitors, Empagli ozin
0

Citations

0

Downloads

267

Views